Eric Verdin

Eric Verdin, M.D., a leading physician-scientist and CEO of the Buck Institute for Research on Aging, dives deep into the complexities of aging. He discusses how metabolic and immune system dysfunctions influence lifespan, focusing on NAD's declining levels and promising longevity interventions like rapamycin. The conversation also delves into practical strategies for maintaining metabolic health, including diet and exercise, while emphasizing the importance of advancing biomarker research to personalize aging care. Verdin's insights shed light on the critical connections between metabolism, immunity, and aging.

Dr. Eric Verdin, President of the Buck Institute for Research on Aging, shares his expertise on combating aging. He discusses how mitochondrial health and NAD levels play vital roles in longevity. Lifestyle interventions, including fasting and physical activity, are highlighted as key strategies. Verdin also explores emerging therapies like CD38 inhibitors that could revolutionize our approach to aging. Listeners are introduced to concepts of biological versus chronological age, emphasizing the importance of personalized health strategies for a longer, healthier life.

Dr. Eric Verdin, CEO of The Buck Institute, discusses the latest updates in longevity research including the future of anti-aging drugs, the question of whether aging is a disease, and the potential for a maximum lifespan. He also shares insights on senescence and senolytics, the impact of genetics and lifestyle on longevity, and the importance of optimizing lifestyle factors for a longer and healthier lifespan.